- Home
- / EASTON BIOPHARMACEUTICALS
EASTON BIOPHARMACEUTICALS
Stock Price
¥34.8
2024-10-29
Market Capitalization
¥6.1 B
2024-10-29
Revenue
¥1.3 B
FY, 2025
EASTON BIOPHARMACEUTICALS Summary
Company Summary
- Overview
- EASTON BIOPHARMACEUTICALS (伊斯頓生物製藥) is a provider of healthcare and medical products. It offers geyoujia, glycopyrronium bromide Injection; fenlipine, Ibuprofen Injection; andoxib, etoricoxib tablets; fendor, parecoxib Sodium for Injection; tianxing, vecuronium bromide for Injection, and other products.
- Type
- Public
- Status
- Active
- Founded
- 2009
- Website
- http://www.eastonpharma.cn
- Cybersecurity rating
- Sectors
Table of Contents
EASTON BIOPHARMACEUTICALS Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥320.5M
- Gross profit (Q1, 2026)
- ¥246.9M
- Net income (Q1, 2026)
- ¥43.3M
- Cash (Q1, 2026)
- ¥326.0M
- EBIT (Q1, 2026)
- ¥46.5M
- Enterprise value
- $5.9B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026